At the heart of this breakthrough lies the discovery of an ‘autonomous driving mechanism’ within cells that dictates directional movement in the absence of external signals. Spearheaded by Professor Won Do Heo and his interdisciplinary team, the study deconstructed how cells internally orchestrate their motility programs through a sophisticated ensemble of protein interactions. This newfound understanding presents transformative implications for decoding the drivers of metastatic cancer and immune system dysregulation.

Central to the investigation was the development of an innovative imaging technique dubbed INSPECT (INtracellular Separation of Protein Engineered Condensation Technique). This technological advancement permits real-time visualization of protein interactions inside living cells by harnessing engineered phase separation phenomena. Phase separation involves the compartmentalization of proteins into condensates, akin to tiny droplets that segregate within the cellular milieu, allowing researchers to observe binding events with remarkable clarity via fluorescent markers.

Leveraging INSPECT, the researchers scrutinized the behavior of Rho family GTPases—specifically Rac1, Cdc42, and RhoA—which are well-known molecular switches regulating cytoskeletal dynamics and cellular locomotion. Prior hypotheses largely attributed cell polarity and motion to spatial segregation of these proteins; however, this study revealed a far more nuanced picture. The direction a cell chooses hinges not merely on protein localization but critically on which particular binding partners the Rho GTPases engage with, establishing distinct signaling circuits that govern straight movement or directional changes.

To visualize these interactions, the team engineered protein clusters using ferritin as a scaffold and DsRed, a fluorescent protein, as a reporter. This enabled detection of 139 binding pairs out of 285 tested combinations between 15 Rho GTPases and 19 effector proteins. Among these, the Cdc42-FMNL interaction emerged as integral to promoting persistent, straight-line migration, while the Rac1-ROCK partnership orchestrated the cellular ability to effectuate directional turns by constructing structural adaptations known as arc stress fibers.

The functional significance of these molecular partnerships was further substantiated through targeted mutagenesis experiments. Modifying the 37th amino acid residue of Rac1, critical for its binding affinity with ROCK, effectively incapacitated the cell’s steering mechanism without affecting its forward propulsion. Consequently, mutant cells lost the capacity to navigate changes in their environment and instead proceeded in rigid linear trajectories, underscoring the Rac1-ROCK axis as a molecular fulcrum for motility adaptability.

Additionally, the dynamic assembly of arc stress fibers facilitated by Rac1-ROCK interactions was observed to enable near-perpendicular directional shifts, a capability vital for cells responding to complex microenvironments. Normal cells modulated their migration speed in response to varying substrates, whereas mutant cells with disrupted Rac1-ROCK binding exhibited speed invariance, revealing the biochemical basis for environmental sensing during cell migration.

Professor Won Do Heo emphasized the paradigm shift introduced by these findings, asserting that cell movement should be reframed not as stochastic drift but as a precisely choreographed process dictated by an intrinsic regulatory network. The ensemble of Rho GTPases and their effectors form an intricate signaling nexus that encodes cellular decision-making in migration, which could be exploited for therapeutic interventions targeting metastatic cancer and immune disorders.

The versatility of the INSPECT platform extends beyond this single study, positioning it as a powerful toolset for probing intracellular molecular interactions with high spatiotemporal resolution. By illuminating the composition and function of protein condensates in live cells, INSPECT opens new avenues for investigating pathological mechanisms in neurobiology, oncology, and beyond.

Published in the prestigious journal Nature Communications, this research exemplifies the synergy achievable through interdisciplinary collaboration across biological sciences and bioengineering. It also highlights the vital role of cutting-edge imaging technologies in deciphering complex cellular behaviors that were previously inscrutable.

As the field advances, the detailed mechanistic insights provided by this work pave the way for novel strategies that could manipulate cell migration patterns, offering hope for mitigating the spread of malignant cells and enhancing tissue regeneration. The modulation of Rho GTPase-effector interactions represents a promising frontier in translational medicine aimed at controlling cellular dynamics at the molecular level.

In conclusion, the elucidation of the autonomous regulatory circuits that govern cell motility marks a significant milestone in cell biology. This research not only deepens our understanding of the molecular code driving directional migration but also heralds new potential for clinical applications targeting diseases characterized by aberrant cell movement.

Subject of Research: Cell migration and intracellular protein interactions.

Article Title: A Rho GTPase-effector ensemble governs cell migration behavior.

News Publication Date: 10 November 2025.

Web References: DOI: 10.1038/s41467-025-64635-0.

Image Credits: KAIST.

Keywords: Cell biology, Rho GTPase, protein phase separation, cellular motility, INSPECT imaging technology, cancer metastasis, immune cell migration.

One particularly vital regulator of dynein is a protein called Lis1. Lis1’s partnership with dynein is essential for proper motor activity, and defects in Lis1 are known to cause lissencephaly, a rare but devastating brain development disorder commonly referred to as “smooth brain” due to its characteristic lack of normal brain folds. Despite the critical nature of this partnership, many aspects of how Lis1 activates dynein and modulates its function have remained mysterious. Now, groundbreaking research led by teams from the Salk Institute and the University of California, San Diego, has captured for the first time short, high-resolution movies revealing the stepwise activation of dynein by Lis1. These movies illustrate sixteen distinct structural conformations of dynein during its interaction with Lis1, providing unprecedented insight into the molecular dance that governs this essential cellular process.

At the molecular level, dynein is a large protein complex composed of two symmetrical halves. Each half includes a stalk domain, which binds to the microtubule; a tail domain, which attaches to the cargo; and a motor domain, which hydrolyzes ATP to generate movement. This ATP-driven motor domain functions somewhat like a biological engine, allowing dynein to “walk” along microtubule tracks. In its inactive state, dynein adopts a locked conformation known as the Phi state, in which it is unable to interact productively with the microtubule, effectively putting the motor “on pause” until activation signals prompt it otherwise.

Prior research had suggested that Lis1 plays the role of an activator or “key” that unlocks dynein, transforming it into an open, active conformation termed the Chi state. However, these conclusions were largely based on static images that captured only snapshots of the dynein-Lis1 interaction at isolated moments, leaving the full dynamic process poorly understood. The new study overcame this limitation by employing time-resolved cryogenic electron microscopy (cryo-EM), a cutting-edge imaging technique that collects a series of structural data points over fractions of a second to generate detailed 3D “movies” of molecular interactions.

Using yeast cells as a model system—chosen for their ability to withstand alterations in dynein and Lis1 levels and the high degree of conservation between yeast and human dynein—the researchers were able to isolate the dynein-Lis1 complex and dramatically lower the temperature to slow the protein motions. This approach made it possible to capture a series of high-definition 3D snapshots that, when combined, depict a continuous timeline from dynein’s locked Phi state through a series of intermediates to the fully activated Chi conformation.

The findings reveal a sophisticated, multi-step activation mechanism. In the first step, one half of the Lis1 dimer binds to the motor domain of dynein. This initial contact disrupts dynein’s locked conformation, “turning on” the motor by prompting a shape change that enhances ATP hydrolysis efficiency and primes the protein for movement. Subsequently, the second half of Lis1 binds to the stalk domain of dynein, further stabilizing the activated conformation and significantly boosting dynein’s motor activity. This two-tiered interaction not only unlocks dynein but also amplifies its capacity to harness ATP energy for rapid and directed transport along the microtubules.

The biological implications of these discoveries extend far beyond the realm of basic cellular biology. Lis1-associated dynein dysfunction is critical in the etiology of lissencephaly and other neurological disorders, which currently have no cure. By deciphering the precise molecular details of dynein activation, this research lays a foundation for rational drug design aimed at restoring proper motor function. For example, small molecules engineered to emulate Lis1’s activating effects on dynein could potentially counteract the impacts of Lis1 mutations or deficiencies.

Furthermore, the high-resolution cryo-EM data give researchers a detailed roadmap of potential binding sites for therapeutic compounds within the dynein-Lis1 complex. Mapping these targetable sites opens new avenues to develop precision medicines that modulate motor protein activity at the atomic level, providing hope for treating not only rare genetic brain disorders but potentially a broader range of neurodegenerative diseases where cellular transport pathways are compromised.

Looking forward, further investigations will focus on dissecting how specific mutations in Lis1 or dynein contribute to disease states by altering their interaction dynamics. Moreover, expanding these studies to human proteins and neuronal cell models will be critical in validating the therapeutic potential suggested by the yeast model findings. These efforts signify an important step toward bridging molecular insights with clinical applications.

This study exemplifies the power of advanced structural biology techniques like time-resolved cryo-EM in transforming our understanding of dynamic protein machines. By transforming still images into molecular movies, researchers can now witness the intricate choreography that underlies fundamental processes such as intracellular transport. The capacity to visualize molecular events as they unfold in near real-time will undoubtedly accelerate the discovery of novel treatments for complex diseases linked to protein dysfunction.

The research was conducted by a collaborative team including Agnieszka Kendrick of the Salk Institute, Andres Leschziner of UC San Diego, and colleagues such as Kendrick Nguyen, Eva Karasmanis, Rommie Amaro, Samara Reck-Peterson, and Wen Ma. Supported by prestigious funding bodies including the American Cancer Society, National Institutes of Health, the Cardiovascular Research Institute of Vermont, Jane Coffin Childs Postdoctoral Fellowship, and the Howard Hughes Medical Institute, this work underscores the importance of interdisciplinary collaboration in pushing the frontiers of biomedical science.

As a distinguished institution, the Salk Institute continues to advance the understanding of life’s most intricate mechanisms, from neuroscience to cancer, aging, and beyond. Founded by Jonas Salk, the architect of the first safe polio vaccine, the Institute embodies a legacy of dedication to uncovering biological truths with the potential to transform human health.

—

Subject of Research: Molecular mechanisms of dynein motor protein activation by Lis1 and implications for neurodevelopmental disorders.

Article Title: Multiple steps of dynein activation by Lis1 visualized by cryo-EM.

News Publication Date: May 23, 2025.

Web References: https://www.nature.com/articles/s41594-025-01558-w

References: Kendrick A., Leschziner A., et al. (2025). Multiple steps of dynein activation by Lis1 visualized by cryo-EM. Nature Structural & Molecular Biology. DOI: 10.1038/s41594-025-01558-w

Image Credits: Agnieszka Kendrick, Salk Institute

Keywords: Dynein, Lis1, motor proteins, microtubules, cryo-electron microscopy, neurodevelopmental disorders, lissencephaly, protein activation, intracellular transport, structural biology, ATP hydrolysis, neurodegeneration